2016 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
His scientific interests lie mostly in Internal medicine, Heart failure, Cardiology, Guideline and Intensive care medicine. His Internal medicine research is multidisciplinary, relying on both Surgery and Evidence-based medicine. His Heart failure research is multidisciplinary, incorporating elements of Mortality rate, Heart disease, Blood pressure and Hazard ratio.
His Cardiology study combines topics from a wide range of disciplines, such as Cohort study and Cardiothoracic surgery. His Guideline study incorporates themes from Platelet aggregation inhibitor, Atrial fibrillation and Management of heart failure. His research on Intensive care medicine also deals with topics like
His primary areas of study are Heart failure, Internal medicine, Cardiology, Intensive care medicine and Ejection fraction. His Heart failure research incorporates themes from Odds ratio, Heart disease, Clinical trial and Emergency medicine. His Internal medicine study typically links adjacent topics like Guideline.
He combines Guideline and Task force in his research. His work deals with themes such as Hydralazine and Hazard ratio, which intersect with Cardiology. His studies deal with areas such as Evidence-based medicine, Quality of care, Nesiritide and Acute decompensated heart failure as well as Intensive care medicine.
Clyde W. Yancy mainly focuses on Heart failure, Internal medicine, Cardiology, Ejection fraction and Heart transplantation. His biological study spans a wide range of topics, including Quality of life, Emergency medicine, Cohort and Intensive care medicine. The study incorporates disciplines such as Text mining, Guideline and Quality of life in addition to Intensive care medicine.
In his study, Kidney disease is strongly linked to Diabetes mellitus, which falls under the umbrella field of Internal medicine. As part of his studies on Cardiology, Clyde W. Yancy frequently links adjacent subjects like Subclinical infection. The various areas that Clyde W. Yancy examines in his Ejection fraction study include Valsartan, Heart malformation and Type 2 diabetes, Dapagliflozin.
His primary areas of study are Heart failure, Internal medicine, Ejection fraction, Cardiology and Intensive care medicine. His Heart failure research integrates issues from Quality, Physical therapy and Association. In general Internal medicine study, his work on Randomized controlled trial, Mineralocorticoid receptor and Pneumonia often relates to the realm of Betacoronavirus and Pandemic, thereby connecting several areas of interest.
His study in Ejection fraction is interdisciplinary in nature, drawing from both Type 2 diabetes, Heart malformation, Valsartan, Natriuretic peptide and Enalapril. His studies in Atrial fibrillation, Heart disease, Sacubitril, Valsartan, Sacubitril and Brain natriuretic peptide are all subfields of Cardiology research. In general Intensive care medicine study, his work on Expert consensus often relates to the realm of Statement, Lifelong learning, Oversight Committee and Solution set, thereby connecting several areas of interest.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno.
European Journal of Heart Failure (2016)
2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler.
Journal of the American College of Cardiology (2013)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
Craig T. January;L. Samuel Wann;Joseph S. Alpert;Hugh Calkins.
Circulation (2014)
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
Sharon Ann Hunt;William T. Abraham;Marshall H. Chin;Arthur M. Feldman.
Circulation (2009)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Glenn N. Levine;Eric R. Bates;James C. Blankenship;Steven R. Bailey.
Circulation (2011)
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler.
Circulation (2013)
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Sharon Ann Hunt;William T. Abraham;Marshall H. Chin.
Circulation (2005)
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond
Donald M. Lloyd-Jones;Yuling Hong;Darwin Labarthe;Dariush Mozaffarian.
Circulation (2010)
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Bernard J. Gersh;Barry J. Maron;Robert O. Bonow;Joseph A. Dearani;Joseph A. Dearani.
Circulation (2011)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Glenn N. Levine;Eric R. Bates;James C. Blankenship;Steven R. Bailey.
Journal of the American College of Cardiology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, Los Angeles
Duke University
Veterans Health Administration
Cleveland Clinic
Northwestern University
Brigham and Women's Hospital
Duke University
Brigham and Women's Hospital
Duke University
University of Mississippi
University of Waterloo
Wrocław University of Science and Technology
Eindhoven University of Technology
Columbia University
University of Tromsø - The Arctic University of Norway
University of Colorado Boulder
Osaka University
University of North Carolina at Chapel Hill
Broad Institute
University of California, San Francisco
University of Oxford
University of Minnesota
Northwestern University
University at Buffalo, State University of New York
Technical University of Munich
World Health Organization